Medicines planning
37 results
Applied filters
Good governance when implementing natalizumab biosimilar
11 December 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.
The licence and supporting evidence for natalizumab biosimilar
14 February 2024One licensed natalizumab biosimilar is available: Tyruko. Learn about the licensed indications and supporting evidence.
Preparing to use natalizumab biosimilar
6 February 2024Natalizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team.
Horizon scanning for ATMPs
13 June 2023Describes what horizon scanning is, how it is performed for the NHS and it's importance for ATMPs.
Annual medicines planning
Our annual Prescribing Outlook output supports planning, implementation and budget planning for medicines every year.
Biosimilars
Regularly updated material to support the introduction of aflibercept, golimumab, ranibizumab, ustekinumab and other biosimilars of interest.
Planning
We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.